Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

Cited by (1,000)

Items 201–300 of 1,000

1. Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy
   Linqi Zhang, Chris Chung, Bor-Shen Hu, He Tian, Yong Sheng Guo, Alexandria J. Kim, Eva Skulsky, Xia Jin, Arlene Hurley, Bharat Ramratnam et al. · 2000 · Journal of Clinical Investigation
2. Innate Immunity in Human Immunodeficiency Virus Infection: Effect of Viremia on Natural Killer Cell Function
   Shyam Kottilil, Tae‐Wook Chun, Susan L. Moir, Shuying Liu, Mary E. McLaughlin, Claire W. Hallahan, Frank M. Maldarelli, Lawrence Corey, Anthony S. Fauci · 2003 · The Journal of Infectious Diseases
3. Premature ageing of the immune system: the cause of AIDS?
   Appay, Victor, Rowland-Jones, Sarah L. · 2002 · Trends in Immunology
4. Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA
   Julio C. C. Lorenzi, Yehuda Z. Cohen, Lillian B. Cohn, Edward F. Kreider, John P. Barton, Gerald H. Learn, Thiago Y. Oliveira, Christy L. Lavine, Joshua A. Horwitz, Allison Settler et al. · 2016 · Proceedings of the National Academy of Sciences
5. Neutralizing Antibodies Do Not Mediate Suppression of Human Immunodeficiency Virus Type 1 in Elite Suppressors or Selection of Plasma Virus Variants in Patients on Highly Active Antiretroviral Therapy
   Justin R. Bailey, Kara G. Lassen, Hung‐Chih Yang, Thomas C. Quinn, Stuart C. Ray, Joel N. Blankson, Robert F. Siliciano · 2006 · Journal of Virology
6. G→A Hypermutation in Protease and Reverse Transcriptase Regions of Human Immunodeficiency Virus Type 1 Residing in Resting CD4 + T Cells In Vivo
   Tara L. Kieffer, Patty Kwon, Richard E. Nettles, Yefei Han, Stuart C. Ray, Robert F. Siliciano · 2005 · Journal of Virology
7. Curing HIV: Seeking to Target and Clear Persistent Infection
   David M. Margolis, Nancie M. Archin, Myron S. Cohen, Joseph J. Eron, Guido Ferrari, J. Víctor García, Cynthia L. Gay, Nilu P Goonetilleke, Sarah Joseph, Ronald I. Swanstrom et al. · 2020 · Cell
8. Functional Heterogeneity of Colony-Stimulating Factor-Induced Human Nonocyte-Derived Macrophages
   Kiyoko S. Akagawa · 2002 · International Journal of Hematology
9. HIV-1 dynamics in vivo: implications for therapy
   Viviana R. Simon, David D. Ho · 2003 · Nature Reviews Microbiology
10. Direct and Quantitative Single-Cell Analysis of Human Immunodeficiency Virus Type 1 Reactivation from Latency
    Olaf Kutsch, Etty N. Benveniste, George M. Shaw, David N. Levy · 2002 · Journal of Virology
11. Latency in Human Immunodeficiency Virus Type 1 Infection: No Easy Answers
    Deborah Persaud, Yan Zhou, Janet D'Angelo Siliciano, Robert F. Siliciano · 2003 · Journal of Virology
12. Position effects influence HIV latency reversal
    Heng‐Chang Chen, Javier P. Martínez, Eduard Valera Zorita, Andreas Meyerhans, Guillaume J. P. Filion · 2016 · Nature Structural & Molecular Biology
13. Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latency
    Vanessa A. Evans, Renée Marije van der Sluis, Ajantha E. Solomon, Ashanti Dantanarayana, Catriona M. McNeil, Roger J Garsia, Sarah Palmer, Rémi Fromentin, Nicolas Chomont, Rafick‐Pierre Sékaly et al. · 2018 · AIDS
14. Parallel evolution of drug resistance in HIV: failure of nonsynonymous/synonymous substitution rate ratio to detect selection
    Keith A. Crandall, Chris R. Kelsey, Hiromi Imamichi, Henry Clifford Lane, Norman P. Salzman · 1999 · Molecular Biology and Evolution
15. Modulation of HIV‐1 infectivity by MAPK, a virion–associated kinase
    Jean Marc Jacqué, Angela Mann, Hervé Enslen, Natalia Sharova, Beda Brichacek, Roger J. Davis, Mario Stevenson · 1998 · The EMBO Journal
16. Current status of latency reversing agents facing the heterogeneity of HIV-1 cellular and tissue reservoirs
    Ait-Ammar, Amina, Kula, Anna, Darcis, Gilles, Verdikt, Roxane, De Wit, Stephane, Gautier, Virginie, Mallon, Patrick W. G., Marcello, Alessandro, Rohr, Olivier, Van Lint, Carine · 2020 · Frontiers in Microbiology
17. Discrepancies between Protease Inhibitor Concentrations and Viral Load in Reservoirs and Sanctuary Sites in Human Immunodeficiency Virus-Infected Patients
    Caroline Solas, Alain Lafeuillade, Philippe Halfon, Stephane Chadapaud, Gilles Hittinger, Bruno Lacarelle · 2002 · Antimicrobial Agents and Chemotherapy
18. Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy
    Antonio Valentin, Margherita Rosati, Daniel J. Patenaude, Angelos E. Hatzakis, Leondios G. Kostrikis, Marios Lazanas, Kathleen M. Wyvill, Robert Yarchoan, George N. Pavlakis · 2002 · Proceedings of the National Academy of Sciences
19. Dynamics of Total, Linear Nonintegrated, and Integrated HIV‐1 DNA In Vivo and In Vitro
    Kersten K. Koelsch, Lin Liu, Richard Haubrich, Susanne J. May, Diane V. Havlir, Huldrych F. Günthard, Caroline C. Ignacio, Paula Campos‐Soto, Susan J. Little, Robert W. Shafer et al. · 2008 · The Journal of Infectious Diseases
20. Chronic CD4+T-Cell Activation and Depletion in Human Immunodeficiency Virus Type 1 Infection: Type I Interferon-Mediated Disruption of T-Cell Dynamics
    Ahmad R. Sedaghat, Jennifer R. German, Tanya M. Teslovich, Joseph Cofrancesco, Chunfa Jie, C. Conover Talbot, Robert F. Siliciano · 2007 · Journal of Virology
21. The frequency of resistant mutant virus before antiviral therapy
    Ruy Miguel Ribeiro, Sebastian Bonhoeffer, Martin A. Nowak · 1998 · AIDS
22. Current Perspectives on HIV-1 Antiretroviral Drug Resistance
    Pinar Iyidogan, Karen S. Anderson · 2014 · Viruses
23. Evolution of Lamivudine Resistance in Human Immunodeficiency Virus Type 1-Infected Individuals: the Relative Roles of Drift and Selection
    Simon D. W. Frost, Monique Nijhuis, Rob Schuurman, Charles A. Boucher, Andrew Brown · 2000 · Journal of Virology
24. CTLA-4+PD-1− Memory CD4+ T Cells Critically Contribute to Viral Persistence in Antiretroviral Therapy-Suppressed, SIV-Infected Rhesus Macaques
    Colleen S. McGary, Claire Deléage, Justin L. Harper, Luca Micci, Susan Pereira Ribeiro, Sara Paganini, Leticia Kuri-Cervantes, Clarisse Benne, Emily S. Ryan, ROBERT S. BALDERAS et al. · 2017 · Immunity
25. Detecting HIV-1 integration by repetitive-sampling -gag PCR
    Megan K. Liszewski, Jianqing J. Yu, Una O’Doherty · 2009 · Methods
26. The role of unintegrated DNA in HIV infection
    Richard D. Sloan, Mark A. Wainberg · 2011 · Retrovirology
27. Characterization of the Follicular Dendritic Cell Reservoir of Human Immunodeficiency Virus Type 1
    Brandon F. Keele, Loubna Tazi, Suzanne Gartner, Yiling Liu, Trever Bradley Burgon, Jacob D. Estes, Tyler C. Thacker, Keith A. Crandall, Justin C. McArthur, Gregory F. Burton · 2008 · Journal of Virology
28. Neuroinvasion and Inflammation in Viral Central Nervous System Infections
    Tobias Dahm, Henriette Rudolph, Christian Schwerk, Horst Schroten, Tobias Tenenbaum · 2016 · Mediators of Inflammation
29. Toward HIV Eradication or Remission: The Tasks Ahead
    David D. Ho · 1998 · Science
30. The Latent Reservoir for HIV-1: How Immunologic Memory and Clonal Expansion Contribute to HIV-1 Persistence
    Alexandra J Murray, Kyungyoon J. Kwon, Donna L. Färber, Robert F. Siliciano · 2016 · The Journal of Immunology
31. HIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads
    Susanna L. Lamers, Rebecca Rose, Ekaterina Maidji, Melissa Agsalda‐Garcia, David J. Nolan, Gary B. Fogel, Marco Salemi, Debra Leiolani Garcia, Paige M. Bracci, William H. Yong et al. · 2016 · Journal of Virology
32. Analysis of Human Immunodeficiency Virus Type 1 Transcriptional Elongation in Resting CD4+T Cells In Vivo
    Kara G. Lassen, Justin R. Bailey, Robert F. Siliciano · 2004 · Journal of Virology
33. Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: Effects on virologic, immunologic, and toxicity parameters
    Mark R Dybul, Tae‐Wook Chun, Christian P Yoder, Bertha Hidalgo, Michael Belson, Kurt Hertogs, Brendan A. Larder, Robin L. Dewar, Cecil H. Fox, Claire W. Hallahan et al. · 2001 · Proceedings of the National Academy of Sciences
34. The origin of genetic diversity in HIV-1
    Redmond P. Smyth, Miles P. Davenport, Johnson Mak · 2012 · Virus Research
35. Quantitation of Replication-Competent HIV-1 in Populations of Resting CD4 + T Cells
    Natalia Soriano-Sarabia, Rosalie Bateson, Noelle Dahl, Amanda M. Crooks, JoAnn D. Kuruc, David M. Margolis, Nancie M. Archin · 2014 · Journal of Virology
36. Establishment and stability of the latent HIV-1 DNA reservoir
    Johanna Brodin, Fabio Zanini, Lina Thebo, Christa Lanz, Göran Bratt, Richard A. Neher, Jan Albert · 2016 · eLife
37. HIV Latency: Should We Shock or Lock?
    Gilles Darcis, Benoît Van Driessche, Carine M. Van Lint · 2017 · Trends in Immunology
38. Biphasic Decay of Latently Infected CD4+T Cells in Acute Human Immunodeficiency Virus Type 1 Infection
    Joel N. Blankson, Diana Finzi, Theodore C. Pierson, Beulah Perdue Sabundayo, Karen R. Chadwick, Joseph B. Margolick, Thomas C. Quinn, Robert F. Siliciano · 2000 · The Journal of Infectious Diseases
39. A Simian Immunodeficiency Virus-Infected Macaque Model To Study Viral Reservoirs That Persist during Highly Active Antiretroviral Therapy
    Jason B. Dinoso, Seyed Alireza Rabi, Joel N. Blankson, Lúcio Gama, Joseph L. Mankowski, Robert F. Siliciano, M. Christine Zink, Janice E. Clements · 2009 · Journal of Virology
40. Critical Role for Env as well as Gag-Pol in Control of a Simian-Human Immunodeficiency Virus 89.6P Challenge by a DNA Prime/Recombinant Modified Vaccinia Virus Ankara Vaccine
    Rama Rao Amara, James M. Smith, Silvija I. Staprans, David C. Montefiori, Francois J. Villinger, John D. Altman, Shawn P. O’Neil, Natalia L. Kozyr, Yan Xu, Linda S. Wyatt et al. · 2002 · Journal of Virology
41. Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques
    Hannah Yuan Chen, Michele Di Mascio, Alan S. Perelson, David D. Ho, Linqi Zhang · 2007 · Proceedings of the National Academy of Sciences
42. In vivo analysis of Fas/FasL interactions in HIV-infected patients.
    Andrew D. Badley, David Harold Dockrell, Alicia Algeciras, Steve Ziesmer, ALAN L. LANDAY, Michael M. Lederman, Elizabeth Connick, Harold A. Kessler, Daniel R. Kuritzkes, David H. Lynch et al. · 1998 · Journal of Clinical Investigation
43. Nuclear landscape of HIV-1 infection and integration
    Marina Lušić, Robert F. Siliciano · 2016 · Nature Reviews Microbiology
44. Productive Infection Maintains a Dynamic Steady State of Residual Viremia in Human Immunodeficiency Virus Type 1-Infected Persons Treated with Suppressive Antiretroviral Therapy for Five Years
    Diane V. Havlir, Matthew C. Strain, Mario Clerici, Caroline C. Ignacio, Daria Trabattoni, Pasquale Ferrante, Joseph K. Wong · 2003 · Journal of Virology
45. Monocyte-derived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence
    Edana Cassol, Massimo Alfano, Priscilla Biswas, Guido Poli · 2006 · Journal of Leukocyte Biology
46. Highly active antiretroviral therapy (Haart) for the treatment of infection with human immunodeficiency virus type 1
    Robert W. Shafer, Dominique Angèle Vuitton · 1999 · Biomedicine & Pharmacotherapy
47. Characterization of Chemokine Receptor Utilization of Viruses in the Latent Reservoir for Human Immunodeficiency Virus Type 1
    Theodore C. Pierson, Trevor L. Hoffman, Joel N. Blankson, Diana Finzi, Karen R. Chadwick, Joseph B. Margolick, Christopher B. Buck, Janet D'Angelo Siliciano, Robert W. Doms, Robert F. Siliciano · 2000 · Journal of Virology
48. Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology
    Stefan Baenziger, Mathias F Heikenwälder, Pål Johansen, Erika Schlaepfer, Ursula Hofer, Regina C. Miller, Simone Diemand, Kenya Honda, Thomas M. Kündig, Adriano Aguzzi et al. · 2008 · Blood
49. Normalization of B Cell Counts and Subpopulations after Antiretroviral Therapy in Chronic HIV Disease
    Susan L. Moir, Angela Malaspina, Jason Ho, Wei Wang, Angela C. DiPoto, Marie A. O’Shea, Gregg A. Roby, JoAnn M. Mican, Shyam Kottilil, Tae‐Wook Chun et al. · 2008 · The Journal of Infectious Diseases
50. HIV Pathogenesis: Dynamics and Genetics of Viral Populations and Infected Cells
    John M. Coffin, Ronald Swanstrom · 2013 · Cold Spring Harbor Perspectives in Medicine
51. Quantification of Human Immunodeficiency Virus Type 1 Proviral Load by a TaqMan Real-Time PCR Assay
    Nathalie Désiré, Axelle Dehée, Véronique Schneider, Christine Jacomet, Christophe P. Goujon, Pierre‐Marie Girard, Willy Rozenbaum, Jean‐Claude Nicolas · 2001 · Journal of Clinical Microbiology
52. Early reduction of immune activation in lymphoid tissue following highly active HIV therapy
    Jan Andersson, Thomas E. Fehniger, Bruce Kendrick Patterson, John C. Pottage, Michelle M. Agnoli, Paul Jones, Homira Behbahani, ALAN L. LANDAY · 1998 · AIDS
53. Directly Infected Resting CD4+T Cells Can Produce HIV Gag without Spreading Infection in a Model of HIV Latency
    Pace, Matthew J., Graf, Erin H., Agosto, Luis M., Mexas, Angela M., Male, Frances, Brady, Troy, Bushman, Frederic D., O'Doherty, Una · 2012 · PLoS Pathogens
54. Memory CCR6+CD4+ T Cells Are Preferential Targets for Productive HIV Type 1 Infection Regardless of Their Expression of Integrin β7
    Patricia Monteiro, Annie Gosselin, Vanessa Sue Wacleche, Mohamed El Far, Elias Anthony Said, Hassen Kared, Nathalie Grandvaux, Mohamed‐Rachid Boulassel, Jean‐Pierre Routy, Petronela Ancuța · 2011 · The Journal of Immunology
55. Effect of ipilimumab on the HIV reservoir in an HIV-infected individual with metastatic melanoma
    Fiona Wightman, Ajantha E. Solomon, Sanjeev Srinivas Kumar, Nicolás Urriola, Kerri J. Gallagher, Bonnie M. Hiener, Sarah Palmer, Catriona M. McNeil, Roger J Garsia, Sharon R. Lewin · 2015 · AIDS
56. Hepatitis C and human immunodeficiency virus infection
    David L. Thomas · 2002 · Hepatology
57. Restrictions to HIV-1 replication in resting CD4+ T lymphocytes
    Xiaoyu Pan, Hanna‐Mari Baldauf, Oliver Till Keppler, O. Fackler · 2013 · Cell Research
58. Targeting HIV latency: pharmacologic strategies toward eradication
    Sifei Xing, Robert F. Siliciano · 2012 · Drug Discovery Today
59. British HIV Association (BHIVA) guidelines for the treatment of HIV‐infected adults with antiretroviral therapy
    BHIVA Writing Committee on behalf of the BHIVA Executive Committee · 2001 · HIV Medicine
60. Highly restricted spread of HIV-1 and multiply infected cells within splenic germinal centers
    Sophie Gratton, Rémi Cheynier, Marie-Jeanne Dumaurier, Éric Oksenhendler, Simon Wain–Hobson · 2000 · Proceedings of the National Academy of Sciences
61. Discontinuation of Antiretroviral Therapy Commenced Early during the Course of Human Immunodeficiency Virus Type 1 Infection, with or without Adjunctive Vaccination
    Martin H. Markowitz, Xia Jin, Arlene Hurley, Viviana R. Simon, Bharat Ramratnam, Michael J. Louie, Geoffrey R. Deschenes, Murugappan Ramanathan, Jr., Shady Barsoum, Jeroen Vanderhoeven et al. · 2002 · The Journal of Infectious Diseases
62. Retroviral DNA Integration—Mechanism and Consequences
    Mary K. Lewinski, Frederic D. Bushman · 2005 · Advances in genetics
63. HIV persists in CCR6+CD4+ T cells from colon and blood during antiretroviral therapy
    Annie Gosselin, Tomas Raul Wiche Salinas, Delphine Planas, Vanessa Sue Wacleche, Yuwei Zhang, Rémi Fromentin, Nicolas Chomont, Éric A. Cohen, Barbara L. Shacklett, Vikram Mehraj et al. · 2016 · AIDS
64. Relationship between latent and rebound viruses in a clinical trial of anti–HIV-1 antibody 3BNC117
    Yehuda Z. Cohen, Julio C. C. Lorenzi, Lisa Krassnig, John P. Barton, Leah Burke, Joy A. Pai, Ching-Lan Lu, Pilar Mendoza, Thiago Y. Oliveira, Christopher Sleckman et al. · 2018 · The Journal of Experimental Medicine
65. The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection.
    David Harold Dockrell, Andrew D. Badley, Jorge S. Villacian, Carrie J. Holtz Heppelmann, Alicia Algeciras, Steve Ziesmer, Hideo Yagita∥, David H. Lynch, Patrick C. Roche, Paul J. Leibson et al. · 1998 · Journal of Clinical Investigation
66. Disrupting T-cell homeostasis: how HIV-1 infection causes disease.
    Daniel C. Douek · 2003 · PubMed
67. Transcriptional Activation of the Integrated Chromatin-Associated Human Immunodeficiency Virus Type 1 Promoter
    Aboubaker El Kharroubi, Graziella Piras, Ralf Zensen, Malcolm A. Martin · 1998 · Molecular and Cellular Biology
68. Modeling within-host HIV-1 dynamics and the evolution of drug resistance: Trade-offs between viral enzyme function and drug susceptibility
    Libin Rong, Michael A. Gilchrist, Zhilan Feng, Alan S. Perelson · 2007 · Journal of Theoretical Biology
69. Preemptive CD8 T-Cell Immunotherapy of Acute Cytomegalovirus Infection Prevents Lethal Disease, Limits the Burden of Latent Viral Genomes, and Reduces the Risk of Virus Recurrence
    Hans-Peter Steffens, Sabine K. Kurz, Rafaela Holtappels, Matthias J. Reddehase · 1998 · Journal of Virology
70. HIV-infected macrophages and microglia that survive acute infection become viral reservoirs by a mechanism involving Bim
    Paul Castellano, Lisa Prevedel, Eliseo A. Eugenín · 2017 · Scientific Reports
71. Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial
    Sarah J. Fidler, Wolfgang Stöhr, Matthew J. Pace, Lucy Dorrell, Andrew M. L. Lever, Sarah Lilian Pett, Sabine Kinloch‐de Loes, Julie Fox, Amanda E. Clarke, Mark Richard Nelson et al. · 2020 · The Lancet
72. Recommendations for measuring HIV reservoir size in cure-directed clinical trials
    Mohamed Abdel‐Mohsen, Douglas D. Richman, Robert F. Siliciano, Michel C. Nussenzweig, Bonnie J. Howell, Javier Martínez‐Picado, Nicolas Chomont, Katharine J. Bar, Xu G. Yu, Mathias D. Lichterfeld et al. · 2020 · Nature Medicine
73. HIV-1 remission and possible cure in a woman after haplo-cord blood transplant
    Jingmei Hsu, Koen van Besien, Marshall Jay Glesby, Savita G. Pahwa, Anne Coletti, Meredith G. Warshaw, Lawrence D. Petz, Theodore Bruce Moore, Ya Hui Chen, Suresh Pallikkuth et al. · 2023 · Cell
74. Emergence of Minor Populations of Human Immunodeficiency Virus Type 1 Carrying the M184V and L90M Mutations in Subjects Undergoing Structured Treatment Interruptions
    Karin Jutta Metzner, Sebastian Bonhoeffer, Marek Fischer, Rose Karanicolas, Kristina Allers, Béda Joos, Rainer K. Weber, Bernard J. Hirschel, Leondios G. Kostrikis, Huldrych F. Günthard et al. · 2003 · The Journal of Infectious Diseases
75. CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue
    Michael L. Penn, Jean‐Charles Grivel, Birgit Schramm, Mark A. Goldsmith, Leonid B Margolis · 1999 · Proceedings of the National Academy of Sciences
76. Progressive contraction of the latent HIV reservoir around a core of less-differentiated CD4+ memory T Cells
    Salma Jaafoura, M. G. de Goër de Herve, Esteban Abelardo Hernandez-Vargas, Houria Hendel, Momen Abdoh, M. C. Mateo, Roman Krzysiek, Mansouria Merad-Boudia, R. Seng, Marc Tardieu et al. · 2014 · Nature Communications
77. Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection
    Jessie Browning, James W. Horner, Massimo Pettoello‐Mantovani, Christina Raker, Sergey Yurasov, Ronald Anthony DePinho, Harris Goldstein · 1997 · Proceedings of the National Academy of Sciences
78. Dual-Affinity Re-Targeting proteins direct T cell–mediated cytolysis of latently HIV-infected cells
    Julia Sung, Joy Pickeral, Liqin Liu, Sherry Stanfield-Oakley, Chia‐Ying K. Lam, Carolina Garrido, Justin Pollara, Celia C. LaBranche, Mattia Bonsignori, Michael Anthony Moody et al. · 2015 · Journal of Clinical Investigation
79. The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy
    Natalie F. McMyn, Joseph Varriale, Emily J. Fray, Carolin Zitzmann, H. H. B. Macleod, Jun Lai, Anushka Singhal, Milica Moskovljevic, Mauro A. Garcia, Brianna M. Lopez et al. · 2023 · Journal of Clinical Investigation
80. Anti-apoptotic Protein BIRC5 Maintains Survival of HIV-1-Infected CD4+ T Cells
    Hsiao-Hsuan Kuo, Rushdy Ahmad, Guinevere Q. Lee, Ce Gao, Hsiao-Rong Chen, Zhengyu Ouyang, Matthew J. Szucs, Dhohyung Kim, Athe M. N. Tsibris, Tae‐Wook Chun et al. · 2018 · Immunity
81. Impact of tuberculosis on HIV-1 replication, diversity, and disease progression.
    Kalonji R. Collins, Miguel E. Quiñones‐Mateu, Zahra Toossi, Eric J. Arts · 2002 · PubMed
82. Direct Evidence of Lower Viral Replication Rates In Vivo in Human Immunodeficiency Virus Type 2 (HIV-2) Infection than in HIV-1 Infection
    Adam MacNeil, Abdoulaye Dieng Sarr, Jean-Louis Sankalé, Seema Meloni, Souleymane Mboup, Phyllis J. Kanki · 2007 · Journal of Virology
83. Persistence of Wild-Type Virus and Lack of Temporal Structure in the Latent Reservoir for Human Immunodeficiency Virus Type 1 in Pediatric Patients with Extensive Antiretroviral Exposure
    Christian Thomas Ruff, Stuart C. Ray, Patricia Kwon, Rebekah L. Zinn, Amanda R. Pendleton, Nancy Hutton, Roxann G. Ashworth, Stephen J. Gange, Thomas C. Quinn, Robert F. Siliciano et al. · 2002 · Journal of Virology
84. A long-term latent reservoir for HIV-1: discovery and clinical implications
    Janet D'Angelo Siliciano · 2004 · Journal of Antimicrobial Chemotherapy
85. Genetic drift and within-host metapopulation dynamics of HIV-1 infection
    Simon D. W. Frost, Marie-Jeanne Dumaurier, Simon Wain–Hobson, Andrew Brown · 2001 · Proceedings of the National Academy of Sciences
86. Pharmacokinetics of Antiretroviral Drugs in Anatomical Sanctuary Sites: The Male and Female Genital Tract
    Laura Else, Stephen R. Taylor, David J. Back, Saye Khoo · 2011 · Antiviral Therapy
87. Barriers for HIV Cure: The Latent Reservoir
    Sergio Castro‐Gonzalez, Marta Colomer-Lluch, Ruth Serra-Moreno · 2018 · AIDS Research and Human Retroviruses
88. Spatial models of virus-immune dynamics
    Georg A. Funk, Vincent A. A. Jansen, Sebastian Bonhoeffer, Timothy Killingback · 2004 · Journal of Theoretical Biology
89. Analysis of Human Immunodeficiency Virus Type 1 Viremia and Provirus in Resting CD4 + T Cells Reveals a Novel Source of Residual Viremia in Patients on Antiretroviral Therapy
    Timothy P. Brennan, John O. Woods, Ahmad R. Sedaghat, Janet D'Angelo Siliciano, Robert F. Siliciano, Claus O. Wilke · 2009 · Journal of Virology
90. Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load
    Laurent M. P. F. Humeau, Gwendolyn K. Binder, Xiaobin Lü, Vladimir Slepushkin, Randall K. Merling, Patricia Echeagaray, Mário José dos Santos Pereira, Tatiana Slepushkina, Scott H. Barnett, Lesia K. Dropulic et al. · 2004 · Molecular Therapy
91. Early Transcription from Nonintegrated DNA in Human Immunodeficiency Virus Infection
    Yuntao Wu, Jon W. Marsh · 2003 · Journal of Virology
92. Absence of HIV-1 Evolution in the Gut-Associated Lymphoid Tissue from Patients on Combination Antiviral Therapy Initiated during Primary Infection
    Teresa H. Evering, Saurabh Mehandru, Paul Rácz, Klara Tenner‐Racz, Michael A. Poles, Amir Figueroa, Hiroshi Mohri, Martin H. Markowitz · 2012 · PLoS Pathogens
93. Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips
    Libin Rong, Alan S. Perelson · 2008 · Mathematical Biosciences
94. HIV-1 gene expression: lessons from provirus and non-integrated DNA
    Yuntao Wu · 2004 · Retrovirology
95. Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV
    Enrico Garaci, Maria Cristina Caroleo, Luigi Aloe, Stefano Aquaro, Mauro Piacentini, Nicola Costa, Alessandra Amendola, Alessandra Micera, Raffaele Caliò, Carlo Federico Perno et al. · 1999 · Proceedings of the National Academy of Sciences
96. Human immunodeficiency virus type 1 RNA Levels in different regions of human brain: Quantification using real-time reverse transcriptase–polymerase chain reaction
    Adarsh M Kumar, Irina Borodowsky, Benny Fernandez, Louis E Gonzalez, Mahendra Kumar · 2007 · Journal of NeuroVirology
97. Recurrent HIV‐1 Integration at theBACH2Locus in Resting CD4+T Cell Populations during Effective Highly Active Antiretroviral Therapy
    Terumasa Ikeda, Junji Shibata, Kazuhisa Yoshimura, Atsushi Koito, Shuzo Matsushita · 2007 · The Journal of Infectious Diseases
98. Regulation of HIV-1 latency by T-cell activation
    Samuel A. Williams, Warner C. Greene · 2007 · Cytokine
99. Fitness Epistasis and Constraints on Adaptation in a Human Immunodeficiency Virus Type 1 Protein Region
    Jack da Silva, Mia Coetzer, Rebecca Nedellec, Cristina Pastore, Donald E. Mosier · 2010 · Genetics
100. Multiple modes of cellular activation and virus transmission in HIV infection: A role for chronically and latently infected cells in sustaining viral replication
     Zvi Grossman, Mark B. Feinberg, William E. Paul · 1998 · Proceedings of the National Academy of Sciences